New cardiovascular risk calculator may impose a burden on 16 million US citizens
HQ Team August 6, 2024: A new cardiovascular disease risk calculator may render 16 million US citizens ineligible for preventive therapy if the
Contineum Therapeutics, Inc., a US San Diego-headquartered biopharmaceutical company’s trial drug may reverse multiple sclerosis damage by potentially restoring movement and function.
Caristo Diagnostics, founded by four Oxford University cardiologists, has developed an AI-assisted software that can detect cardiac events a decade in advance.
Flexible, gel-like synthetic tubes can replace human veins during heart bypass operations to reroute blood flow, according to engineers at the University of
Researchers have added two additional risk factors — untreated vision loss and high LDL cholesterol — to 12 other steps to identify dementia,
Seventeen types of cancer are common in US millennials and the incidence rate for some forms is two to three times higher in
HQ Team August 4, 2024: The WHO has warned about the rising global incidence of hypervirulent and multi-resistant Klebsiella Pneumoniae (hvKp) infections. The
The US drug regulator has granted permission for expanded use of British pharmaceutical company, GSK Plc’s endometrial cancer drug.
HQ Team August 2, 2024: Mpox or monkeypox cases have seen a 160% surge in the African region this year compared to the